USNA
Usana Health Sciences·NYSE
--
--(--)
--
--(--)
7.82 / 10
Outperform
Analyst coverage is absent, but insider selling raises concern. Fund‑flow metrics are good (7.8/10) with small and medium investors net inflowing, while large and extra‑large investors show outflows, yielding a mixed capital sentiment.
Fund Flow Rating
Is money flowing into or out of USNA?
- USNA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.82/10 (Outperform).
